Real-time enrollment status for this focal segmental glomerulosclerosis clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 6:36 AM UTC
| NCT Number | NCT02235857 |
| Recruiting Status | Recruiting |
| Condition | Focal Segmental Glomerulosclerosis |
| Phase | Clinical Trial |
| Target Enrollment | 35 participants |
| Active Locations | 12 sites in the US |
| Sponsor | Kaneka Medical America LLC |
| Last Updated on CT.gov | April 30, 2025 (Apr 30, 2025) |
As of July 13, 2026: Clinical trial NCT02235857 is currently recruiting participants. This clinical trial study for focal segmental glomerulosclerosis is actively seeking new participants at 12 locations across the United States. The study is sponsored by Kaneka Medical America LLC. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT02235857 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 12 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT02235857 was last updated Apr 30, 2025 (April 30, 2025). HelloStudys verifies this status automatically.